CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Antipsychotic Drugs Market by Class (First Generation, Second Generation, Third Generation), Indication (Bipolar Disorders, Dementia, Schizophrenia) - Global Forecast 2024-2030
... to reach USD 10.42 billion in 2024, at a CAGR 8.01% to reach USD 16.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Antipsychotic Drugs Market. It offers ... Read More
-
Neurology Patient Monitoring Market by Device (Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors), Disease Type (Epilepsy, Parkinson's Disease, Sleep Disorders), End-User - Global Forecast 2024-2030
... 5.18 billion in 2023 and expected to reach USD 5.55 billion in 2024, at a CAGR 7.90% to reach USD 8.84 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
South & Central America Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson\'s Disease, Tremor, Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
... Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others) The South & Central America deep brain simulation market is expected to grow from US$ 27.53 million in ... Read More
-
Diaphragm Pacing Therapy System Market by Product (Diaphragm Pacemaker, External Diaphragm Pacemaker), Application (Amyotrophic Lateral Sclerosis, Spinal Cord Injury) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 5.40 billion in 2024, at a CAGR 7.39% to reach USD 8.29 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Middle East & Africa Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson\'s Disease, Tremor, Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
... Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others) The Middle East & Africa deep brain simulation market is expected to grow from US$ 25.64 million in ... Read More
-
South & Central America Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)
... End User (Hospital & Clinics and Ambulatory Surgical Center) The South & Central America glioma treatment market is expected to grow from US$ 117.14 million in 2022 to US$ 227.74 million by 2030. It is ... Read More
-
Amyotrophic Lateral Sclerosis Treatment Market by Treatment (Medication, Stem Cell Therapy), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
... 2023 and expected to reach USD 790.52 million in 2024, at a CAGR 7.73% to reach USD 1,237.05 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Amyotrophic Lateral ... Read More
-
Interventional Neurology Devices Market by Type (Aneurysm Coiling & Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices), End-User (Ambulatory Care Centers, Hospitals, Neurology Clinics) - Global Forecast 2024-2030
... estimated at USD 2.02 billion in 2023 and expected to reach USD 2.17 billion in 2024, at a CAGR 8.97% to reach USD 3.69 billion by 2030. Global Interventional Neurology Devices Market FPNV Positioning Matrix ... Read More
-
Neurology Devices Market by Product (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurostimulation Devices), End User (Ambulatory Surgery Centers, Hospitals) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 10.10 billion in 2024, at a CAGR 7.81% to reach USD 16.03 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neurology ... Read More
-
Clinical Trial Patient Recruitment Services Market by Therapeutic Areas (Anti-Infective, Cardiovascular, Central Nervous System), Phase (Phase I, Phase II, Phase Ill), Age Group - Global Forecast 2024-2030
... was estimated at USD 1.16 billion in 2023 and expected to reach USD 1.27 billion in 2024, at a CAGR 9.63% to reach USD 2.22 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Brain Biomarkers Market by Product (Biomarker Analyzers, Biomarker Test Kits), Indication (Alzheimer's Disease, Huntington's Disease, MND & ALS), End-Users, Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 10.54 billion in 2024, at a CAGR 17.90% to reach USD 28.33 billion by 2030. Global Brain Biomarkers Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Brain Tumor Therapeutics Market by Type (Glioblastoma, Meningioma, Metastatic Brain Tumors), Therapy (Chemotherapy, Gene Therapy, Immunotherapy), Patient Age Group, Distribution Channel, End-User - Global Forecast 2024-2030
... USD 3.03 billion in 2023 and expected to reach USD 3.28 billion in 2024, at a CAGR 8.24% to reach USD 5.28 billion by 2030. Global Brain Tumor Therapeutics Market FPNV Positioning Matrix The FPNV ... Read More
-
Pediatric Imaging Market by Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound), Application (Cardiology, Gastroenterology, Neurology), End-User - Global Forecast 2024-2030
... expected to reach USD 38.57 billion in 2024, at a CAGR 8.43% to reach USD 62.77 billion by 2030. Global Pediatric Medical Device Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Anxiety Drugs Market by Type (Generic Drugs, Patent Medicine), Application (Help Sleep, Treat Anxiety, Treat Premature Ejaculation) - Global Forecast 2024-2030
... expected to reach USD 19.03 billion in 2024, at a CAGR 8.78% to reach USD 31.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anxiety Drugs Market. It ... Read More
-
Neuroprotection Market by Product (Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists), Treatment (Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Brain Injury), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 16.20 billion in 2024, at a CAGR 9.86% to reach USD 28.52 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neuroprotection Market. ... Read More
-
Europe Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)
... & Clinics and Ambulatory Surgical Center) The Europe glioma treatment market is expected to grow from US$ 959.99 million in 2022 to US$ 1,905.10 million by 2030. It is estimated to grow at a CAGR ... Read More
-
Lewy Body Dementia Treatment Global Market Report 2024
... Parkinson’s diseaseCovering: Mallinckrodt Pharmaceuticals Co.; BioArctic AB; Sumitomo Pharma Co. Ltd.; Jazz Pharmaceuticals Inc.; Allergan plc Lewy Body Dementia Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Headache Disorders Global Market Report 2024
... X-Rays; CT Scan; Magnetic Resonance Imaging (MRI)4) By Route Of Administration: Oral; Parenterals5) By End-User: Hospitals; Specialty Clinics; HomecareCovering: Teva Pharmaceutical Industries Ltd.; Hikma Pharmaceuticals PLC; Dr. Reddy's Laboratories Ltd; Novartis AG; Eli Lilly and ... Read More
-
Behavioural Health Software Market Analysis and Forecast To 2033: By Component (Software, Services), Application (Clinical, Financial, Administrative), Delivery Model (Ownership Model, Subscription Model), Disorder Type (Anxiety, Post-Traumatic Stress Disorder (PSTD), Substance Abuse, Schizophrenia, Bipolar Disorders, And Others), End-Use (Hospitals, Community Clinics, Private Practices, Others), And Region
... And Others), End-Use (Hospitals, Community Clinics, Private Practices, Others), And Region The global behavioral health software market size was approximately USD 4.5 billion in 2023 and is expected to grow at a compound annual growth ... Read More
-
Dementia Associated with Alzheimer's Disease Market (Drug Class: Cholinergic/Cholinesterase Inhibitors, Memantine, Combined Drugs, Others; Distribution Channel: Hospital Pharmacies, Retail, Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2023-2031
... Alzheimer's Disease Market – Scope of Report TMR’s report on the global dementia associated with Alzheimer’s disease market studies the past as well as the current growth trends and opportunities to gain valuable insights of ... Read More
-
Global Encephalitis Vaccine Market Research Report 2024(Status and Outlook)
... infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus. ... Read More
-
Global Tick-borne Encephalitis Inactivated Vaccine Market Research Report 2024(Status and Outlook)
... The major symptoms occurring as a result of TBE infection are headache, agitation, high temperature (fever), sickness (vomiting), and confusion. The Global Tick-borne Encephalitis Inactivated Vaccine Market Size was estimated at USD 562.57 million in ... Read More
-
Global Schizophrenia Treatments Market Research Report 2024(Status and Outlook)
... 8836.21 million in 2023 and is projected to reach USD 9834.51 million by 2029, exhibiting a CAGR of 1.80% during the forecast period. This report provides a deep insight into the global Schizophrenia Treatments market ... Read More
-
Schizophrenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... a chronic disorder that profoundly impacts individuals' lives, is characterized by an abnormal interpretation of reality and leads to various behavioral changes, including hallucinations and delusions. Schizophrenia treatment is an ongoing journey, with medications playing ... Read More
-
Global Schizophrenia Therapeutics Market Research Report 2024(Status and Outlook)
... the patient's condition. The Global Schizophrenia Therapeutics Market Size was estimated at USD 8836.21 million in 2023 and is projected to reach USD 9834.51 million by 2029, exhibiting a CAGR of 1.80% during the forecast ... Read More
Research Assistance
